The effectiveness of homocysteine-lowering therapy on stroke prevention is still unclear. Although randomized controlled epidemiological trials have yielded mixed findings, a multicenter trial did not show any beneficial effect. Genetic studies are still lacking. Therefore, we report on a female patient with transient ischemic attacks and the thermolabile variant of methylenetetrahydrofolate reductase (TT genotype), who benefited from supplemental therapy for homocysteine lowering.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
successful treatment
4
treatment brain
4
brain ischemia
4
ischemia supplementation
4
supplementation therapy
4
therapy patient
4
patient hyperhomocysteinemia
4
hyperhomocysteinemia effectiveness
4
effectiveness homocysteine-lowering
4
homocysteine-lowering therapy
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!